Acadia Healthcare

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Acadia Healthcare posts robust Q4 results, eyes growth opportunities ahead

Acadia Healthcare's strong Q4 performance, growth strategies, and financial stability position it well for future expansion and success in the healthcare sector.
While facing challenges such as labor costs and Medicaid redeterminations, the company's focus on IT investments, strategic partnerships, and revenue diversification mitigates risks.
Opportunities in M&A, value-based programs, and revenue growth present avenues for Acadia to capitalize on market trends, enhance patient care, and drive shareholder value.

Acadia Healthcare excels in Q1 2023, navigates challenges for growth

Acadia Healthcare's strong Q1 performance, robust financial position, and strategic growth initiatives position the company for continued success and resilience.
While facing challenges such as labor inflation and benefit cost increases, Acadia's proactive approach and focus on efficiency and optimization are key to maintaining profitability.
Opportunities in expanding CTC business, achieving Medicaid rate increases, and leveraging investments in technology and marketing underscore Acadia's potential for sustained growth and operational excellence.

Acadia Healthcare excels in Q2 2023, eyes growth opportunities

Acadia Healthcare's Q2 2023 performance reflects strong financial growth and operational excellence.
The company's focus on quality care, technology, and strategic acquisitions positions it for continued success.
While facing challenges like regulatory uncertainties, Acadia Healthcare remains committed to growth and value creation.
Opportunities for expansion through acquisitions, partnerships, and operational enhancements are key focus areas for future growth.

Acadia Healthcare reports robust Q3 results and outlines growth strategies

Acadia Healthcare's Q3 performance reflects strong revenue and earnings growth, supported by operational efficiency and cost management.
While facing challenges such as start-up costs and operating expenses, the company is well-positioned to capitalize on growth opportunities.
Strategic initiatives in employee engagement, partnerships, and digitization highlight Acadia's commitment to sustainable growth and patient care.
Overall, Acadia's financial outlook remains positive, with a focus on expansion, cost optimization, and enhancing healthcare services.

Acadia Healthcare reports strong Q4 earnings and outlines growth plans

Acadia Healthcare delivered strong financial results in Q4 2023, with revenue growth, improved EBITDA, and EPS, driven by same facility revenue growth and strategic initiatives.
The company's focus on quality care, technology investments, and expansion plans position it well for continued growth and market leadership in the behavioral health care sector.
While facing challenges in labor expenses and seasonal impacts, Acadia's opportunities for growth through expansions, CTC services, and partnerships signal a positive outlook for 2024.
Overall, Acadia Healthcare's performance, strengths, and opportunities indicate a promising trajectory for sustained growth and profitability in the coming year.

Acadia Healthcare reports robust Q1 growth amidst strategic expansions

Acadia Healthcare delivered strong financial performance in Q1 2024, with revenue, EBITDA, and EPS showing significant growth. The company's strategic focus on expansion, acquisitions, and service enhancements contributed to its positive results.
While facing challenges with patient volumes and overhead costs, Acadia remains resilient and anticipates a stronger performance in the latter half of the year. Opportunities for growth through facility expansions, technology investments, and funding support position the company for continued success.
Overall, Acadia Healthcare's Q1 earnings call highlights its solid performance, strategic strengths, ongoing challenges, and promising opportunities for future growth. The company's commitment to delivering value to stakeholders and enhancing patient care underscores its position in the healthcare industry.

Acadia Healthcare posts robust Q3 results amidst legal challenges and growth opportunities

Acadia Healthcare's Q3 2024 performance reflects solid revenue growth and EBITDA expansion, underpinned by a commitment to quality care and operational efficiency.
While facing challenges from legal issues and lower volume growth, the company is actively addressing these hurdles and investing in future growth opportunities.
By navigating challenges, leveraging strengths, and capitalizing on growth opportunities, Acadia Healthcare is poised for continued success in the behavioral health care sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.

LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Shareholders Are Invited To Join The Schall Law Firm's Inquiry Into Acadia Healthcare Company Inc For Possible Securities Fraud

SAN DIEGO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP ( www.JohnsonFistel.com ) is investigating whether Acadia Healthcare Company, Inc. (NASDAQ: ACHC), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under the federal securities laws.

Johnson Fistel Announces Investigation into Acadia Healthcare Company, Inc.

Acadia Healthcare Co. Inc. plummeted Friday after the operator of behavioral-healthcare facilities disclosed that it was the subject of a government investigation into how patients were treated.

Acadia Healthcare's stock plunges after government probe into patient care

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) issued the following statement with respect to a government investigation separately disclosed today by the Company. Acadia is cooperating fully with the authorities regarding this matter. “Ensuring we provide the highest quality of care is personal for me and the number one priority for my colleagues across the Company,” said Acadia Chief Executive Officer Chris Hunter. “We take seriously our patient care and comp.

Acadia Healthcare Issues Statement with Respect to Government Investigation

Acadia Healthcare Co has agreed to pay $19.85 million to settle allegations the company billed for medically unnecessary inpatient behavior health services, the U.S. Justice Department said on Thursday.

Acadia Healthcare to pay $19.85 million to settle allegations of improper billing, DOJ says

iLearningEngines Holdings Inc

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims iLearningEngines, Inc. (NASDAQ: AILE) and Acadia Healthcare Company, Inc. (NASDAQ: ACHC). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Is Investigating iLearningEngines and Acadia and Encourages Investors to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Shareholders Should Contact The Schall Law Firm About A Securities Fraud Inquiry Into Acadia Healthcare Company Inc

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Acadia Healthcare Company, Inc. Is Being Looked Into For Securities Law Violations And Affected Investors Are Urged To Lend A Hand

PHILADELPHIA, PA / ACCESSWIRE / September 24, 2024 / Kehoe Law Firm, P.C. is investigating whether certain officers or directors of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "Acadia") (NASDAQ:ACHC) failed to manage Acadia Healthcare in an acceptable manner, in breach of their fiduciary duties to Acadia and its shareholders, and whether Acadia Healthcare and its shareholders suffered harm.

Acadia Healthcare - Investors of Acadia Healthcare Stock Encouraged to Contact Kehoe Law Firm, P.C. - ACHC

LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Invites Shareholders To Help Investigate Whether Acadia Healthcare Company Inc Defrauded The Public

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) breached their fiduciary duties to Acadia Healthcare and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of the Acadia Healthcare board of directors or senior management failed to manage Acadia Healthcare.

ACADIA HEALTHCARE INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Marathon Petroleum Corporation's Directors and Officers for Breach of Fiduciary Duties – ACHC

LOS ANGELES, CA / ACCESSWIRE / September 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Acadia Healthcare Company, Inc. May Have Violated Securities Laws And Impacted Investors Should Join The Schall Law Firm's Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Looking Into Acadia Healthcare Company Inc For Possible Securities Fraud And Shareholders Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Acadia Healthcare Company, Inc. May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Join An Investigation

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Looking Into Acadia Healthcare Company Inc For Possible Securities Fraud And Impacted Stockholders Are Urged To Reach Out

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Acadia Healthcare Company, Inc. (ACHC) And Encourages Shareholders to Connect

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients.

Did Acadia Healthcare Company, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ACHC

ACHC is expected to benefit from improved volumes, patient day growth and expansion initiatives.

Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why

LOS ANGELES, CA / ACCESSWIRE / September 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Acadia Healthcare Company, Inc. May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Join An Inquiry

NEW YORK, NY / ACCESSWIRE / September 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients.

Acadia Healthcare Company, Inc. Being Investigated on Behalf of Acadia Healthcare Company, Inc. Investors. Contact Levi & Korsinsky For Details.

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the Company”) (NASDAQ: ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm!

LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Investigating Whether Acadia Healthcare Company Inc Committed Securities Fraud And Affected Stakeholders Are Urged To Take Part

NEW YORK, NY / ACCESSWIRE / September 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients.

Levi & Korsinsky Reminds Acadia Healthcare Company, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ACHC

NEW YORK--(BUSINESS WIRE)---- $ACHC #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the Company”) (NASDAQ: ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC. Investigation Details On Sunday, September 1, 2024, The New York Times published a repo.

Acadia Healthcare Company, Inc. (ACHC) INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm!

LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

News for Acadia Healthcare Stock (ACHC)